Hirokazu Taniguchi

Also affiliated with Nagasaki University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC”.

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Cell Reports(2022)10.1016/j.celrep.2022.110814

N/A

0.737DataRank · unranked

135 citations

Rebecca Caeser, Shweta S. Chavan, Yingqian A. Zhan, Andrew Chow, Parvathy Manoj +15 more

Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.05.014

N/A

0.736DataRank · unranked

134 citations

Hirokazu Taniguchi, Joseph M. Chan, Yingqian A. Zhan, Xiaoping Chen, Juan Qiu +13 more

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01186-z

N/A

0.685DataRank · unranked

95 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +25 more

Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy

Virchows Archiv(2024)10.1007/s00428-024-03764-1

N/A

0.345DataRank · unranked

9 citations

Yuka Takahashi, Hirokazu Taniguchi, Tetsuro Ochi, Haruhi Makino, Shinichi Makita +7 more

Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets

Translational Lung Cancer Research(2023)10.21037/tlcr-22-794

N/A

0.312DataRank · unranked

7 citations

Hirokazu Taniguchi, Hiroyuki Yamaguchi, Hiroshi Gyotoku, Daisuke Sasaki, Norihito Kaku +16 more

Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer

Nature Communications(2024)10.1038/s41467-024-50063-z

N/A

0DataRank · unranked

35 citations

Philip H. Choi, Yu Chi Yang, Jacob A. Boyer, Adele Whaley, Priya Pancholi +16 more

Role of CD38 in anti-tumor immunity of small cell lung cancer

Frontiers in Immunology(2024)10.3389/fimmu.2024.1348982

N/A

0DataRank · unranked

6 citations

Shweta S. Chavan, Andrew Chow, Joseph M. Chan, Hiroshi Mukae, Charles M. Rudin +2 more

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1997

N/A

0DataRank · unranked

0 citations

Hirokazu Taniguchi, Yu Zhan, Maysun Hasan, Shweta S. Chavan, Fathema Uddin +15 more